Widely read:
Stockwire
• Wealth Insight - Mar 2024
vis-a-vis: Cipla vs Dr Reddy's Labs
Putting two market leaders face-to-face
01-Mar-2024•Value Research
Top Picks
Welcome to the New Value Research!
2 min read•By Value Research
RBI is offering NRIs up to 7% on dollar deposits
5 min read•By Ujjal Das
Why gold funds just shut their biggest taps
3 min read•By Ujjal Das
New episodes every Friday
The AI revolution worth having
Forget the trillions being bet on AI. The revolution that matters is the one you can build for yourself, for free, right now.
Other Episodes
-
Old file, new company
The market misprices stocks using outdated assumptions. The opportunity lies in that gap.
-
When 'this too shall pass' doesn't
For 30 years, I have told readers to ride out every crisis. The US-Iran war is the exception, and the reason matters more than the news itself.
-
Read the signal, not the list
The Prime Minister's seven appeals are about consumption. The signal they carry is about the rupee.
-
The Omaha show is over
Sometimes waiting for too long can lead to missed opportunities
More stories from Wealth Insight March 2024
Explore the edition
'Monkey see, monkey do' won't do
3 min read•By Dhirendra Kumar
Cover Story: Imitation investing
19 min read•By Value Research
Market Reporter - Newsmakers of February 2024
1 min read•By Value Research
Stock Story: From Lakmé to Zudio
1 min read•By Value Research
Big moves of the past three months
1 min read•By Value Research
IPO corner: A snapshot into D-Street debutants
1 min read•By Value Research
Market Barometer: Is the market overvalued?
1 min read•By Value Research
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
